<?xml version="1.0" encoding="UTF-8"?>
<p>PD is the second most prevalent condition after AD, and also develops slowly over time [
 <xref rid="B47-molecules-26-01107" ref-type="bibr">47</xref>]. PD can be identified and clinically characterised via motor impairment, which includes bradykinesia, rigidity, resting tremor and postural instability [
 <xref rid="B48-molecules-26-01107" ref-type="bibr">48</xref>]. PD cases can be divided into sporadic (sPD) and familial (fPD), the latter of which represents approximately 20â€“25% of all PD cases. A common hallmark of sPD and fPD is the presence of intracellular inclusions, termed Lewy bodies [
 <xref rid="B49-molecules-26-01107" ref-type="bibr">49</xref>,
 <xref rid="B50-molecules-26-01107" ref-type="bibr">50</xref>].
</p>
